Trenchant Biosystems
Trenchant Bio is making cell and gene therapies (CGT) more affordable and accessible to patients.
We were founded in 2022 to create cell therapy manufacturing technologies and processes to be scalable, efficient, rapid, and affordable. Our singular focus is on solving the CGT manufacturing problem that is currently too lengthy, cumbersome, and unreliable. Our founding team has first-hand experience with the current CGT manufacturing process, and is developing technologies and process improvements to improve manufacturing.
